Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» CymaBay Initiates Ph III Study of Primary Biliary Cholangitis Drug
CymaBay Initiates Ph III Study of Primary Biliary Cholangitis Drug
CymaBay Initiates Ph III Study of Primary Biliary Cholangitis Drug
Submitted by
admin
on October 30, 2018 - 11:22am
Source:
CP Wire
News Tags:
CymaBay
primary biliary cholangitis
clinical trials
seladelpar
Headline:
CymaBay Initiates Ph III Study of Primary Biliary Cholangitis Drug
snippet:
1 in 1000 women over the age of 40 lives with PBC
The company also has clinical trials underway for NASH
Do Not Allow Advertisers to Use My Personal information
